| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $101.79M | - | |
| Dir | 1.55M | $80.47M | - | |
| Dir | 1.19M | $61.61M | - | |
| CFO | 1.12M | $57.89M | - | |
| VP | 594.7K | $30.81M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2020 | Senner Christopher J. | EVP And CFO | Sale+OE | 20,000 | $25.00 | $500,000.00 | -13.5% | |
| Jul 20, 2020 | Haley Patrick J.56 | EVP, Commercial | Sell | 3,151 | $25.36 | $79,909.36 | -2.7% | |
| Jun 8, 2020 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 26,000 | $22.56 | $586,560.00 | -17.0% | |
| Jun 4, 2020 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $22.96 | $2,296,000.00 | -23.5% | |
| May 22, 2020 | Garber Alan M50 | Director | Sell | 36,111 | $24.42 | $881,830.62 | -74.0% | |
| May 21, 2020 | Marchesi Vincent T | Director | Sale+OE | 40,000 | $24.64 | $985,600.00 | -30.7% | |
| May 20, 2020 | Haley Patrick J.56 | EVP, Commercial | Sell | 3,151 | $24.99 | $78,743.49 | -2.7% | |
| May 18, 2020 | Willsey Lance | Director | Sale+OE | 30,000 | $26.26 | $787,800.00 | -7.5% | |
| May 18, 2020 | Scangos George A77 | Director | Sell | 75,000 | $25.96 | $1,947,000.00 | -9.5% | |
| May 14, 2020 | Willsey Lance | Director | Sale+OE | 15,000 | $25.26 | $378,900.00 | -3.9% |